IT1143012B - Composti 6-aril pirimidinici per il trattamento e la prevenzione di infezioni virali e per stimolare la produzione di interferone - Google Patents

Composti 6-aril pirimidinici per il trattamento e la prevenzione di infezioni virali e per stimolare la produzione di interferone

Info

Publication number
IT1143012B
IT1143012B IT48119/80A IT4811980A IT1143012B IT 1143012 B IT1143012 B IT 1143012B IT 48119/80 A IT48119/80 A IT 48119/80A IT 4811980 A IT4811980 A IT 4811980A IT 1143012 B IT1143012 B IT 1143012B
Authority
IT
Italy
Prior art keywords
pyrimidinic
interferone
aril
stimulate
prevention
Prior art date
Application number
IT48119/80A
Other languages
English (en)
Italian (it)
Other versions
IT8048119A0 (it
Inventor
Wendell Wierenga
Harvey Irving Skulnich
Dale Alan Stringfellow
Patricia Evelyn Fast
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of IT8048119A0 publication Critical patent/IT8048119A0/it
Application granted granted Critical
Publication of IT1143012B publication Critical patent/IT1143012B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT48119/80A 1979-03-19 1980-03-10 Composti 6-aril pirimidinici per il trattamento e la prevenzione di infezioni virali e per stimolare la produzione di interferone IT1143012B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2220579A 1979-03-19 1979-03-19
US7985079A 1979-09-28 1979-09-28

Publications (2)

Publication Number Publication Date
IT8048119A0 IT8048119A0 (it) 1980-03-10
IT1143012B true IT1143012B (it) 1986-10-22

Family

ID=26695670

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48119/80A IT1143012B (it) 1979-03-19 1980-03-10 Composti 6-aril pirimidinici per il trattamento e la prevenzione di infezioni virali e per stimolare la produzione di interferone

Country Status (7)

Country Link
JP (1) JPH0627070B2 (enrdf_load_html_response)
CH (1) CH646958A5 (enrdf_load_html_response)
DE (1) DE3008693A1 (enrdf_load_html_response)
FR (1) FR2451918A1 (enrdf_load_html_response)
GB (1) GB2048250B (enrdf_load_html_response)
IT (1) IT1143012B (enrdf_load_html_response)
NL (1) NL8001568A (enrdf_load_html_response)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0111440A1 (en) * 1982-10-15 1984-06-20 Ciba-Geigy Ag 2-Aminopyrimidines, their production and use
US4795812A (en) * 1985-02-05 1989-01-03 The Upjohn Company 4-substituted-6-aryl-pyrimidine compounds
GB9012311D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
CA2269681A1 (en) * 1996-12-12 1998-06-18 Pharmacia & Upjohn Company Llc Use of a 6-aryl pyrimidine compound for treating multiple sclerosis
US6495558B1 (en) 1999-01-22 2002-12-17 Amgen Inc. Kinase inhibitors
CA2359680A1 (en) * 1999-01-22 2000-07-27 David M. Armistead Kinase inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2688019A (en) * 1951-08-25 1954-08-31 Burroughs Wellcome Co 6-aryl-2,4-diamino pyrimidines and process of preparing same
US2723977A (en) * 1953-07-29 1955-11-15 Searle & Co 5, 6-disubstituted 2-amino-4-pyrimidols
US2723978A (en) * 1954-01-14 1955-11-15 Searle & Co 2-amino-5-alkenyl-6-phenyl-4-pyrimidols
US2710867A (en) * 1954-03-12 1955-06-14 Searle & Co New 2-amino-4-pyrimidol derivatives
US2704285A (en) * 1954-06-17 1955-03-15 Searle & Co 2-amino-5-(lower alkyl)-6-substituted phenyl-4-pyrimidols
US2748121A (en) * 1954-06-17 1956-05-29 Searle & Co 6-nitroaryl derivatives of 2-amino-4-pyrimidols
US3281420A (en) * 1966-01-27 1966-10-25 Searle & Co Carboxylic acid [2-(2-amino-4-azido-6-phenyl-5-pyrimidinyl)-1-methylethylidene] hydrazides and intermediate
US3412094A (en) * 1967-06-21 1968-11-19 Searle & Co 5-alkyl-2-amino-4-azido-6-phenylpyrimidines and congeners
US3932617A (en) * 1974-05-24 1976-01-13 The Upjohn Company Interferon induction

Also Published As

Publication number Publication date
IT8048119A0 (it) 1980-03-10
DE3008693A1 (de) 1980-10-02
FR2451918B1 (enrdf_load_html_response) 1984-01-06
JPH0517451A (ja) 1993-01-26
JPH0627070B2 (ja) 1994-04-13
NL8001568A (nl) 1980-09-23
GB2048250B (en) 1983-04-27
FR2451918A1 (fr) 1980-10-17
GB2048250A (en) 1980-12-10
CH646958A5 (de) 1984-12-28

Similar Documents

Publication Publication Date Title
IT8248659A0 (it) Impiego di desferriossammina per il trattamento di affezioni artritiche
IT1058597B (it) Processo per la preparazione continua di polibutilentereftalati
IT1075017B (it) Procedimento per il trattamento di estratti antocianinici
BR8202931A (pt) Compostos composicao farmaceutica processo para tratamento de infeccoes virais processo para preparacao de tais compostos composto intermediario para tais compostos e processo para preparacao do dito intermediario
IT1234215B (it) Forma di dosaggio per il trattamento di malattie cardiovascolari
IT7950379A0 (it) Procedimento per il trattamento di acque di scarico
IT1069277B (it) Procedimento ed impianto per la depurazione di alogenosilani
IT1101714B (it) Metodo per il trattamento di fanghi rossi
IT7948616A0 (it) Procedimento di trattamento di poliesteri per ridurre al minimo la formazione di acetaldeide
TR20880A (tr) Akrilonitrilin aritilmasi
IT1194748B (it) Composizioni farmaceutiche per il trattamento di osteopatie
IT1038893B (it) Processo per la preparazione di alchilbenzoli
IT1096358B (it) Procedimento di ammossidazione per la preparazione di acrilonitrile
IT1064331B (it) Processo per la preparazione di d-mannite
IT1058978B (it) Processo per la preparazione di acetacetilarilamidi
IT1143012B (it) Composti 6-aril pirimidinici per il trattamento e la prevenzione di infezioni virali e per stimolare la produzione di interferone
IT1062997B (it) Processo per la preparazione di 5 acetacetilaminobenzimidazolone
IT1122111B (it) Procedimento per la purificazione di resorcina grezza
IT1063583B (it) Processo per la preparazione di p alchilfenoli
IT1097374B (it) Processo per la preparazione di poliglicidileteri di fenoli poliidrossilici
IT1123187B (it) Processo per la preparazione di l-alfa-glicerilfosforilcolina
IT1159815B (it) Composizione medicinale per il trattamento di certe neurovirosi
IT1080511B (it) Procedimento per la purificazione di nistatina
IT1070568B (it) Processo per la preparazione di butendioldiacetato
FI800099A7 (fi) Behandling av svartlut

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19990331